103 related articles for article (PubMed ID: 12616737)
1. [Catecholamine metabolism in Parkinson's disease with depression].
Selikhova MV; Kogan BM; Ustinova IL
Zh Nevrol Psikhiatr Im S S Korsakova; 2003; 103(1):39-42. PubMed ID: 12616737
[TBL] [Abstract][Full Text] [Related]
2. [Catecholamine metabolism in different forms of Parkinson's disease].
Selikhova MV; Kogan BM; Serkin GV; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):37-40. PubMed ID: 12378880
[TBL] [Abstract][Full Text] [Related]
3. A validation study of depressive syndromes in Parkinson's disease.
Starkstein SE; Merello M; Jorge R; Brockman S; Bruce D; Petracca G; Robinson RG
Mov Disord; 2008 Mar; 23(4):538-46. PubMed ID: 18074376
[TBL] [Abstract][Full Text] [Related]
4. [Depression in patients with Parkinson's disease].
Sławek J; Derejko M; Lass P
Neurol Neurochir Pol; 2003; 37(2):351-64. PubMed ID: 14558483
[TBL] [Abstract][Full Text] [Related]
5. [Abnormalities of catecholamine metabolism in Parkinson's disease (author's transl)].
Nagatsu T
Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1781-8. PubMed ID: 6117927
[No Abstract] [Full Text] [Related]
6. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
Pålhagen SE; Carlsson M; Curman E; Wålinder J; Granérus AK
Acta Neurol Scand; 2008 May; 117(5):295-304. PubMed ID: 18279483
[TBL] [Abstract][Full Text] [Related]
7. Hedonic tone and its mood and cognitive correlates in Parkinson's disease.
Spalletta G; Fagioli S; Meco G; Pierantozzi M; Stefani A; Pisani V; Caltagirone C; Pontieri FE; Assogna F
Depress Anxiety; 2013 Jan; 30(1):85-91. PubMed ID: 23300113
[TBL] [Abstract][Full Text] [Related]
8. Social support and psychological outcome in people with Parkinson's disease: Evidence for a specific pattern of associations.
Simpson J; Haines K; Lekwuwa G; Wardle J; Crawford T
Br J Clin Psychol; 2006 Nov; 45(Pt 4):585-90. PubMed ID: 17076966
[TBL] [Abstract][Full Text] [Related]
9. [Involvement of serotonergic system in the pathogenesis of non-motor symptoms of Parkinson's disease].
Shutov AA; Dondova AI
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(11):67-71. PubMed ID: 19008805
[TBL] [Abstract][Full Text] [Related]
10. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study.
Feldmann A; Illes Z; Kosztolanyi P; Illes E; Mike A; Kover F; Balas I; Kovacs N; Nagy F
Mov Disord; 2008 Jan; 23(1):42-6. PubMed ID: 17973326
[TBL] [Abstract][Full Text] [Related]
11. [Modifications of catecholamine metabolism under the effect of a decarboxylase inhibitor associated with L-dopa and desipramine in patients with depressive and parkinsonian syndromes].
Geissbuhler F; Bartholini G; Gaillard JM; Tissot R
Encephale; 1971; 60(3):189-209. PubMed ID: 5119348
[No Abstract] [Full Text] [Related]
12. [Depressive symptoms and the Idiopathic Parkinson's Syndrome (IPS): a review].
Giupponi G; Pycha R; Erfurth A; Hausmann A; Conca A
Neuropsychiatr; 2008; 22(2):71-82. PubMed ID: 18606109
[TBL] [Abstract][Full Text] [Related]
13. Urinary profile of catecholamines and metabolites in Parkinson patients with deep brain stimulation.
Guimarães J; Vieira-Coelho MA; Moura E; Afonso J; Rosas MJ; Vaz R; Garrett C
Eur J Neurol; 2014 Feb; 21(2):353-6. PubMed ID: 23679894
[TBL] [Abstract][Full Text] [Related]
14. Depression leading to attempted suicide after bilateral subthalamic nucleus stimulation for Parkinson's disease.
Doshi PK; Chhaya N; Bhatt MH
Mov Disord; 2002 Sep; 17(5):1084-5. PubMed ID: 12360564
[TBL] [Abstract][Full Text] [Related]
15. Major depression and health-related quality of life in Parkinson's disease.
Jones CA; Pohar SL; Patten SB
Gen Hosp Psychiatry; 2009; 31(4):334-40. PubMed ID: 19555793
[TBL] [Abstract][Full Text] [Related]
16. Alexithymia in Parkinson's disease is related to severity of depressive symptoms.
Costa A; Peppe A; Carlesimo GA; Pasqualetti P; Caltagirone C
Eur J Neurol; 2006 Aug; 13(8):836-41. PubMed ID: 16879293
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease: the effect of L-dopa therapy on urinary free catecholamines and metabolites.
Davidson DF; Grosset K; Grosset D
Ann Clin Biochem; 2007 Jul; 44(Pt 4):364-8. PubMed ID: 17594783
[TBL] [Abstract][Full Text] [Related]
18. Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy.
Chan-Palay V
Adv Neurol; 1993; 60():438-46. PubMed ID: 8093581
[No Abstract] [Full Text] [Related]
19. [Reactivity of the DOPA--dopamine--noradrenaline--adrenaline system in epileptics].
Karlov VA; Gleĭzer MA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(6):810-5. PubMed ID: 6410626
[TBL] [Abstract][Full Text] [Related]
20. A cognitive-behavioral treatment package for depression in Parkinson's disease.
Dobkin RD; Allen LA; Menza M
Psychosomatics; 2006; 47(3):259-63. PubMed ID: 16684945
[No Abstract] [Full Text] [Related]
[Next] [New Search]
